Is Cardio Risk Check useful for menopause?

Whether a 'Cardio Risk Check' is useful during menopause depends on what exactly is measured. Menopause increases cardiovascular risk due to declining estrogen, affecting LDL cholesterol, blood pressure, and inflammatory markers. A test covering these classic risk factors may provide some insight, but it cannot replace clinical risk stratification (e.g., SCORE2). The provided context lacks specific studies or product details on a Cardio Risk Check for menopause. Moreover, the context repeatedly warns that consumer DNA tests often miss clinically relevant genes (e.g., CYP2D6, VKORC1) and are not validated for medication dosing. Without menopause-specific validation, the utility of such a check remains unclear. An evidence-based risk assessment should always involve a physician who considers hormonal status, lifestyle, and family history. Therefore, be cautious of overblown claims – the test may offer a rough indication but is no substitute for a clinical evaluation.